United States · 
Who invested in Perceive Biotherapeutics?
Perceive Biotherapeutics's investors include Deerfield and Catalio Capital Management.
United States · Series B startup
Who invested in Perceive Biotherapeutics
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Perceive Biotherapeutics and see its new rounds in your feed.Sign up free
Funding summaryUpdated 27 Oct 2026
$78Mraised across 1 round since 2023, from 1 source
- Latest round
- Series B, $78MJan 2023
- Investors
- 2
The rounds
- Jan 2023Series B$78M
Source recordedSEC filing: $40M sold, first sale Dec 2022
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Perceive Biotherapeutics
How much has Perceive Biotherapeutics raised?
Perceive Biotherapeutics has raised $78M across 1 round since 2023.
When did Perceive Biotherapeutics last raise?
Perceive Biotherapeutics's most recent round was a Series B of $78M in Jan 2023.
What was Perceive Biotherapeutics's biggest round?
Its most recent round, $78M in Jan 2023, is also its largest on record.
Who backed Perceive Biotherapeutics first?
Perceive Biotherapeutics's first round on record, in Jan 2023, was backed by Deerfield and Catalio Capital Management.
What stage is Perceive Biotherapeutics at?
Perceive Biotherapeutics's latest named round is a Series B, in Jan 2023.
Where is Perceive Biotherapeutics based?
Perceive Biotherapeutics is based in the United States.
Companies like Perceive Biotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.